Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
Bio-Thera Solutions has partnered with STADA Arzneimittel for the commercialization of BAT2506, a biosimilar candidate to Simponi (golimumab). 30 May 2024
Cell and gene therapy (CGT) manufacturing specialist Ori Biotech has introduced its IRO platform, aiming to streamline and scale the manufacturing process for C 30 May 2024
Johnson & Johnson has announced positive results from the Phase III MDD3001 trial for seltorexant, a selective orexin-2 receptor antagonist. 30 May 2024
New research published in Nature Communications shows another potential application for GLP-1 agonists, adding to established benefits in type 2 diabetes, obesi 30 May 2024
An Expert View from Danie du Plessis, executive vice president, medical affairs at Kyowa Kirin, and chair of the Medical Affairs Professional Society (MAPS) boa 29 May 2024
With the annual meeting of the American Society of Clinical Oncology (ASCO) now just days away, multiple large drugmakers have lifted the lid on data that they 29 May 2024
Contract research organization IQVIA has published its Global Oncology Trends report for 2024, projecting a significant rise in cancer cases. 29 May 2024
Less than two years after it was launched, San Francisco-based startup Cartography Biosciences has announced a deal with nearby biotech major, Gilead Sciences. 29 May 2024
After more than 30 years with neuroscience-focused biopharma Neurocrine Biosciences, founder and chief executive Kevin Gorman is to retire in October—albeit sta 29 May 2024